Meta's Health and Wellness Ad Policy Explained for Telehealth

Meta's health and wellness ad policy is not a single document — it is a set of interrelated policies that cover healthcare products, body image, before-and-after content, sensitive health conditions, and prescription medication promotion. For telehealth brands, this means that a single ad may touch three or four different policy areas simultaneously. Understanding how the policies interact — and which provisions are most commonly cited in rejections — is more useful than reading the policies in isolation.

The policies that matter most for telehealth brands in 2026 are: the healthcare and medicines policy (which covers prescription drug advertising and online pharmacy requirements), the personal health and body image policy (which covers before-and-after content and body idealization), the sensitive health topics policy (which covers conditions like obesity, ED, and mental health that Meta treats with heightened care), and the general deceptive content prohibition (which the FTC endorsement and claim standards feed into).

The Healthcare and Medicines Policy

Meta's healthcare and medicines policy restricts ads that promote the sale of prescription medications, online pharmacies without proper certification, and drug products without FDA approval. For telehealth brands, the policy is triggered by ads that name or describe specific prescription medications as the product being offered or advertised. Advertising access to a telehealth consultation — where a provider may prescribe a medication if appropriate — is treated differently from advertising the specific prescription product. The former is allowed with appropriate framing; the latter requires specific advertiser-level certification including LegitScript approval.

Meta's policy distinguishes between information about health conditions (educational, generally allowed) and promotion of specific drug products as treatments (restricted). A telehealth brand that runs ads explaining what GLP-1 medications are and inviting viewers to consult with a licensed provider is operating in the educational-informational space. A brand that runs ads offering "get semaglutide shipped to your door" is operating in the drug promotion space and triggering the healthcare and medicines policy. The creative strategy implication is clear: lead with the consultation and the provider access, not the medication.

The Personal Health and Body Image Policy

Meta's personal health and body image policy prohibits ads that depict or imply body idealization in ways that could be harmful, before-and-after transformation content in health contexts, and weight loss ads targeted to users under 18. For telehealth brands advertising GLP-1 or other weight management services, this policy is the most frequently cited in ad rejections. The before-and-after prohibition is strict on Meta — both explicit comparison imagery and implied transformation sequences in video are covered.

The body image policy also restricts ads that use language targeting body dissatisfaction. Ad copy like "tired of not fitting into your old clothes," "embarrassed by your weight," or "finally get the body you deserve" can trigger this policy because it uses language that Meta's guidelines consider to be body-shaming or body-dissatisfaction-targeting. The compliant alternative focuses on health goals rather than appearance — "better energy and mobility," "improved metabolic health," "feel like yourself again" — language that addresses the genuine health outcomes patients are seeking without exploiting body image insecurity.

Sensitive Health Topics and How Meta Categorizes Conditions

Meta's sensitive health topics policy covers a list of conditions that the platform treats as requiring heightened care in advertising. These include obesity and overweight, erectile dysfunction and sexual health, mental health conditions, substance use, infertility, and genetic conditions, among others. Ads that name these conditions, target audiences based on them, or use imagery associated with them are reviewed more scrutinously than general health advertising.

For telehealth brands, the practical implication is that ads naming specific health conditions in the headline or primary creative text face additional review delays and higher rejection rates. "Treat your obesity with GLP-1 therapy" will face different review treatment than "connect with a provider for personalized weight management support." The second version addresses the same patient need without triggering the sensitive health topics review tier. Many telehealth brands find that removing specific condition names from their primary ad text — moving that specificity to the landing page — reduces rejection rates substantially without losing conversion effectiveness.

Targeting Restrictions Under Meta's Health Policy

Meta restricts the use of health-related behavioral and interest targeting for certain ad categories. Specifically, Meta has removed health-condition-related targeting options that were previously available — advertisers can no longer target users based on interest categories related to specific health conditions. For telehealth brands, this means that demographic and behavioral targeting strategies that rely on health condition interests need to be replaced with alternative targeting approaches.

The most effective alternatives for telehealth brand targeting on Meta in 2026 are broad demographic targeting with strong creative qualification (letting the creative itself filter for relevant audiences), lookalike audiences built from existing patient data, and retargeting of website visitors and video viewers. These approaches do not rely on Meta's health interest targeting and are therefore not subject to the same restrictions. They also tend to perform better at scale because lookalike and retargeting audiences are typically better quality than interest-based targeting for high-intent health decisions.

How Meta's Review Process Works for Telehealth

Meta's ad review process uses automated systems for initial screening and human reviewers for contested or complex cases. Telehealth ads often require human review because of the health content, which adds time to the review process compared to non-health advertising. The typical review timeline for telehealth ads that do not match known rejection patterns is 24-48 hours. Ads that trigger automated flags — because of health keywords, before-and-after patterns, or condition-specific language — may take longer or may be automatically rejected and require appeal.

Understanding this review process has practical implications for campaign launch timing. Telehealth brands should not submit ads for review on the day they want them to run — the review timeline may exceed 24 hours, and for ads that require appeal, the process can take several days. Building review time into your campaign calendar reduces last-minute compliance pressure and the temptation to submit borderline creative when you need something live immediately. See our full analysis of why telehealth ad accounts get flagged on Meta for the account-level risk factors that affect individual ad reviews.

Writing Ads That Pass Meta's Health Review

The telehealth ads that pass Meta's health review most consistently in 2026 share several characteristics. They lead with patient experience rather than medical claims — the convenience of the consultation, the quality of the provider relationship, the ease of getting care — rather than with specific treatment outcomes or medication names. They use imagery that shows the consultation experience or general wellness without before-and-after comparisons or body-focused transformation content. They include required disclosures naturally within the ad flow rather than in hard-to-read footnotes. And they direct to landing pages that are consistent with the ad content, without making claims on the landing page that would not pass ad review themselves.

The landing page consistency point deserves emphasis. Meta's review sometimes catches violations on the destination page rather than in the ad creative itself — and if the landing page is rejected, the ad that links to it will not run even if the ad creative itself was approved. Building a Meta-specific landing page review into your campaign process — separate from the ad creative review — reduces rejections from this source. See our companion guide to Meta ad policies for telehealth for a full overview of how the policies stack.